NextSense is redefining neurological health monitoring with their wearable technology platform. Their device provides continuous brain activity monitoring outside clinical settings, offering unprecedented insights for people looking to improve sleep quality, sleep disorders, and additional neurological conditions planned in the future. By enabling real-time data collection in patients' daily lives, NextSense is closing critical gaps in neurological care while building a valuable data repository that will fuel future innovations. Their team brings together expertise in neuroscience, AI, and medical device development, perfectly aligning with Capita3's investment thesis in deep tech healthcare solutions.
Widely acknowledged as the most advanced platform for engaging with EEG brain signals, the Company also has extensive partnerships in clinical research and related applications, such as early detection of epileptic seizures.
Financing:
We invested in the Series A round and are joining existing investors including Ascension Ventures, ISelect, Merus Capital and Google.
Product Launch:
NextSense is building a neurotech platform that is initially focused on sleep enhancement technologies for the growing consumer sleep tech market, The Company is addressing the need for accessible, noninvasive, and efficacious sleep monitoring and sleep enhancement solutions.
The Company is at the commercial stage with the NextSense biosensing smartbud product - Tone, which was soft launched with pre-orders.at the Consumer Electronics Show (CES) in Las Vegas, January 2025. The Company plans to begin shipping product in Q3 2025.
The Tone smartbud platform, using advanced electroencephalography (EEG) and AI, is aimed at enhancing sleep quality through real-time audio feedback using proven sleep enhancing methods, while also functioning as premium wireless earbuds. Planned follow-on applications include enhancing focus and reducing anxiety.
Team:
The Company was founded by CEO Jonathan (JB) Berent, with Caitlin Shure as the Company’s lead expert in consumer neurotech products, and Duy Pham, VP of Engineering and formerly instrumental in Apple’s health tech platform. The NextSense team comprises experienced professionals in neurotechnology, biosensing, software engineering, and health tech, with backgrounds at Google, Apple, and leading research institutions, ensuring expertise in product development and market strategy.
Company Description:
NextSense is building a neurotech platform that is initially focused on sleep enhancement technologies for the growing consumer sleep tech market, The Company is addressing the need for accessible, noninvasive, and efficacious sleep monitoring and sleep enhancement solutions. Tone Buds feature advanced electroencephalography (EEG) technology that precisely monitors your brain activity during sleep. The Company was part of an exploratory research project at X, Google/Alphabet’s “Moonshot Factory," with Google investing significantly in development of the core technology.
The Company's innovative earbuds called TONE, are designed with clinical-grade electroencephalography sensors to provide accurate sleep tracking and real-time audio enhancement. Developed by NextSense, Tone Buds respond intelligently to your brain's patterns, delivering customized audio experiences that help deepen restoration during critical sleep phases.
Follow-on applications include enhancing focus and reducing anxiety. Known as the most advanced platform for engaging with EEG brain signals, the Company also has extensive partnerships in clinical research and related applications, including early detection of epileptic seizures and drug development studies for other indications. The Company is leveraging key partnerships in consumer tech and distribution channels for its impending product launch.
